Marimed Inc.

Name: Marimed Inc. standardized financial statements, quarterly
Creator: Listed

MRMDOTCCIK 1522767HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$41.9m, Q2 FY2026

Operating income$418.0k, Q2 FY2026

Net income−$3.6m, Q2 FY2026

Marimed Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	38.8	38.9	37.9	40.4	40.6	38.9	37.9	39.5	40.8	41.7	39.5	41.9
Cost of revenue	$m	22.0	21.6	21.5	23.5	23.8	26.3	22.8	23.6	24.4	31.1	24.2	25.7
Gross profit	$m	16.8	17.3	16.5	16.9	16.8	12.7	15.1	15.9	16.4	10.5	15.3	16.2
Selling, general and administrative	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Operating income	$m	3.3	2.4	2.0	1.0	1.3	(1.5)	(0.9)	1.0	1.6	(4.5)	0.1	0.4
Interest expense	$m	2.5	1.6	1.6	1.7	1.7	1.9	1.8	1.8	1.8	2.2	2.0	2.0
Income tax	$m	4.5	0.5	1.7	0.9	0.7	4.9	2.8	0.7	2.8	(2.7)	2.7	2.0
Net income	$m	(4.3)	(10.2)	(1.3)	(1.7)	(1.0)	(8.3)	(5.5)	(1.4)	(2.9)	(4.6)	(3.8)	(3.6)
Diluted EPS	$ per share	(0.01)	not reported	0.00	0.00	0.00	not reported	(0.01)	0.00	(0.01)	not reported	(0.01)	(0.01)
Basic EPS	$ per share	(0.01)	not reported	0.00	0.00	0.00	not reported	(0.01)	0.00	(0.01)	not reported	(0.01)	(0.01)

Balance sheet

Cash and equivalents$6.6m, Q3 FY2025

Long-term debt$82.7m, Q2 FY2026

Shareholders' equity$43.2m, Q2 FY2026

Marimed Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	13.3	14.6	15.2	10.2	9.8	7.3	7.2	6.1	6.6	not reported	not reported	not reported
Current assets	$m	50.8	51.4	54.9	53.1	56.7	53.5	58.0	57.1	60.1	59.3	60.8	58.4
Total assets	$m	191	196	201	209	213	207	208	204	206	203	201	197
Current liabilities	$m	35.3	30.9	35.5	40.7	44.6	50.0	55.3	50.9	56.6	59.1	63.8	63.8
Total liabilities	$m	92.0	107	114	121	126	129	134	131	137	138	148	147
Long-term debt	$m	31.2	not reported	76.6	79.5	79.4	78.2	77.4	77.5	76.2	76.0	82.5	82.7
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	79.9	68.9	67.7	67.3	66.6	58.5	57.8	56.9	54.3	50.0	46.5	43.2

Cash flow

Operating cash flow$2.2m, Q2 FY2026

Capital expenditure$298.0k, Q2 FY2026

Marimed Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	7,900	3,234	3,210	3,185	803	(413)	1,293	297	2,676	3,429	949	2,219
Capital expenditure	$k	5,963	5,381	3,368	4,968	2,566	1,058	266	309	559	33.0	373	298

Diluted shares (weighted)399.60m, Q2 FY2026

Marimed Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	381	343	361	373	375	380	381	383	390	393	397	400

Shares outstanding: 403.04m at Aug 10, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.